OakChart

Sanuwave Health Inc

SNWVHealthcare·Medical Devices·USA·Nano·NASD·Nov 11 • 3:59 PM ET

1.78-0.10 (-5.32%)
2026-11-12 02:12 CET
Market cap
16.17 USD m
Revenue, TTM
41.03 USD m
Net income, TTM
2.57 USD m
Free cash flow, TTM
2.60 USD m
EPS diluted, TTM
-0.39
P/E
-
Compare

Price

SNWV against its 20, 50 and 200-day averages
2050200missearnings
0.0010.0020.0030.001.1M2.1MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26SNWVclose 1.7820-day 4.4750-day 4.62200-day 12.541.78

95.1% under the 52-week high of 36.20 on 11 Nov 2025. 52-week low 1.58 on 11 Nov 2026. Last 15 sessions, 291.8% high to low

Volume 3.63× normal · the line is the 50-bar volume average

Profile

SNWV
52-week range, 0% of the way up
1.7536.20

SANUWAVE Health, Inc. is a medical device company providing directed energy products into the wound care space. It engages in the development and marketing of directed energy products that utilize ultrasound technology. The company was founded on May 6, 2004 and is headquartered in Eden Prairie, MN.

Employees55
IPOSep 30, 2009
Beta1.57
ATR, 14d0.57
Rel volume3.63
Short float2.21%
Insider own5.42%
Inst own46.82%

Snapshot

6 groups

Valuation

Index-
Market Cap15.31M
Enterprise Value28.35M
Income2.57M
Sales41.03M
Book/sh0.33
Cash/sh0.76
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees55
IPOSep 30, 2009

Ratios

P/E-
Forward P/E-
PEG-
P/S0.37
P/B5.37
P/C2.33
P/FCF5.89
EV/EBITDA-
EV/Sales0.69
Quick Ratio0.76
Current Ratio1.17
Debt/Eq6.88
LT Debt/Eq4.51
Option/ShortNo / Yes

Earnings

EPS (ttm)-0.39
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y- -
Sales past 3/5Y38.05% 61.12%
EPS Y/Y TTM136.21%
Sales Y/Y TTM-0.61%
EPS Q/Q-135.58%
Sales Q/Q-25.08%
EarningsNov 10 AMC
EPS/Sales Surpr.- -

Ownership

Insider Own5.42%
Insider Trans0.00%
Inst Own46.82%
Inst Trans-15.21%
ROA7.55%
ROE-
ROIC16.37%
Gross Margin73.42%
Oper. Margin-4.54%
Profit Margin6.27%
SMA20-60.20%
SMA50-61.47%
SMA200-85.81%
Trades-

Technical

Shs Outstand8.60M
Shs Float8.14M
Short Float2.21%
Short Ratio2.33
Short Interest0.18M
52W High36.20 -95.08%
52W Low1.75 1.71%
Volatility53.13% 17.51%
ATR (14)0.57
RSI (14)22.84
Beta1.57
Rel Volume3.63
Avg Volume77.27K
Volume280,628

Performance

Perf Week-68.94%
Perf Month-68.27%
Perf Quarter-62.68%
Perf Half Y-90.60%
Perf YTD-94.03%
Perf Year-94.96%
Perf 3Y-66.10%
Perf 5Y-95.68%
Perf 10Y-97.36%
Recom1.00
Target Price40.00
Prev Close1.88
Price1.78
Change %-5.32%

Analyst ratings

latest 2 of 2
DateActionAnalystRating changeTargetImplied
Sep 03, 2025InitiatedNNorthland CapitalOutperform$55+2,989.9%
Jul 29, 2025InitiatedRRoth CapitalBuy$49+2,652.8%

Peers

Mkt cap
TickerCompanyMkt cap
RCELAVITA Medical Inc429.73M
SMTISanara MedTech Inc290.43M
ORGOOrganogenesis Holdings Inc136.29M
ELUTElutia Inc40.75M
MDXGMimedx Group Inc484.47M
TELATELA Bio Inc42.51M
ECORElectroCore Inc71.13M
ELMDElectromed Inc206.84M
TCMDTactile Systems Technology Inc607.74M
CUPRCuprina Holdings (Cayman) Ltd10.13M

Insider trading

12 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Opaleye Management Inc.10% OwnerApr 30 '26Sale16.1525,000403,7755,500May 04 04:05 PM
Opaleye Management Inc.10% OwnerMay 01 '26Sale16.1110,581170,4655,000May 04 04:05 PM
Opaleye Management Inc.10% OwnerApr 28 '26Sale18.4746,288854,8197,500Apr 30 04:10 PM
Opaleye Management Inc.10% OwnerApr 29 '26Sale17.2524,360420,1526,500Apr 30 04:10 PM
Opaleye Management Inc.10% OwnerApr 17 '26Sale20.4616,267332,84110,000Apr 21 06:17 PM
Opaleye Management Inc.10% OwnerApr 21 '26Sale20.502024,142954,798Apr 21 06:17 PM
MANCHESTER MANAGEMENT CO LLCDirector by DeputizationDec 11 '25Sale31.2813,500422,27770,499Dec 15 05:22 PM
MANCHESTER MANAGEMENT CO LLCDirector by DeputizationDec 12 '25Sale21.046,500136,78963,999Dec 15 05:22 PM
MANCHESTER MANAGEMENT CO LLCDirector by DeputizationDec 08 '25Sale30.75125,4003,856,050881,390Dec 10 09:21 PM
MANCHESTER MANAGEMENT CO LLCDirector by DeputizationDec 09 '25Sale30.588,785268,679872,605Dec 10 09:21 PM
MANCHESTER MANAGEMENT CO LLCDirector by DeputizationDec 10 '25Sale30.398,625262,129863,980Dec 10 09:21 PM
MANCHESTER MANAGEMENT CO LLCDirector by DeputizationDec 08 '25Sale31.602,00063,2032,000Dec 10 09:21 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
QQQSInvesco NASDAQ Future Gen 200 ETFAUM: 20.53M
IWCiShares Micro-Cap ETFAUM: 1.22B

News

latest 14 of 54
  • Sanuwave's Q3 Confirms The Reimbursement Downside: System Sales Collapse, A Covenant Waiver, And A Business Now Leaning On Consumables (Earnings Whispers) -5.32%
  • Sanuwave Announces Q3 FY2026 Financial Results (GlobeNewswire)
  • Sanuwave Will Host a Conference Call on November 11, 2026 at 8:30 AM (ET) to Present Q3 2026 Financial Results (GlobeNewswire) -15.53%
  • Sanuwave Health Comments on 2027 Medicare Physician Fee Schedule Rate for Ultramist (GlobeNewswire) -60.73%
  • SANUWAVE Health Inc (SNWV) (Q2 2026) Earnings Call Highlights: Record Applicator Sales Offset ... (GuruFocus.com)
  • Sanuwave Announces Q2 FY2026 Financial Results (GlobeNewswire)
  • Earnings To Watch: SANUWAVE Health Inc (SNWV) Q2 2026 -- GF Value Sees 166% Upside (GuruFocus.com)
  • Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results (GlobeNewswire)
  • Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6-$9.8 Million, Above High End of Revised Guidance (GlobeNewswire) +6.22%
  • Sanuwave Health Updates Second Quarter 2026 Guidance (GlobeNewswire) -41.99%
  • SANUWAVE Health Inc (SNWV) Q1 2026 Earnings Call Highlights: Record Revenue Amid Market Challenges (GuruFocus.com) +18.08% -9.87%
  • Sanuwave Announces Revenues and Financial Results for Q1 FY2026 (GlobeNewswire)
  • Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial Results (GlobeNewswire)
  • Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6-$9.7 Million, Up 3-4% Year-over-Year (GlobeNewswire) +14.37%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-10-0.160--0.1658.58--
2026Q22026-08-06-0.080--0.0799.74--
2026Q12026-05-12-0.170-0.140-0.1689.629.601
2025Q42026-03-260.9000.1700.02513.3913.252
2025Q32025-11-070.4600.3200.46311.4511.432
2025Q22025-08-080.010-0.0900.00710.1610.141
2025Q12025-05-09-0.660--0.6649.34--
2024Q42025-03-21---1.49210.33--
2024Q32024-11-08---6.4889.36--
2024Q22024-08-13--1.7747.16--
2024Q12024-05-10---1.4635.79--
2023Q42024-03-22--5.9966.99--
2023Q32023-11-13---9.9534.95--
2023Q22023-08-11---4.6764.68--
2023Q12023-05-12---8.5313.78--
2022Q42023-04-03---5.5505.50--

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-0.050-0.050-19.2641.031.58
2025FY0.4100.4250.41044.0544.18
2026FY--0.080--51.35
2027FY-0.370--64.50

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-05-0610016.5016.5016.50
2026Q4S2026-04-1620116.8016.5017.10
2026Q4S2026-03-2720116.8016.5017.10
2026Q4S2026-03-2510018.6018.6018.60
2026Q4S2026-01-0910118.6018.6018.60
2026Q4S2025-12-0510119.0019.0019.00
2026Q4S2025-11-1110118.9918.9918.99
2026Q4S2025-11-1010118.9918.9918.99
2026Q4R2026-03-271010.400.400.40
2026Q4R2026-03-251000.460.460.46
2026Q4R2026-01-091010.460.460.46
2026Q4R2025-11-111010.470.470.47
2026Q4R2025-11-101010.470.470.47
2026Q4E2026-05-061000.070.070.07

Estimate history

EPS, annual-15-29.168-19.264-30.683-19.721-7.024-12.191-7.4130.408-0.3867
Period201720182019202020212022202320242025TTM
EPS, quarterly-6.488-1.492-0.6640.0070.4630.025-0.168-0.079-0.165
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual0.7391.851.0294.05713.0116.74220.39832.63444.05141.03
Period201720182019202020212022202320242025TTM
Sales, quarterly9.3610.3269.34210.16411.45113.0949.6199.7398.579
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual0.3710.4150.7831.2551.2841.4633.0418.5448.5898.602
Period201720182019202020212022202320242025MRQ
Shares, quarterly3.158.5448.5488.5688.5768.5898.5948.6028.602
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue41.0344.0532.6320.4016.7413.014.061.031.85
Cost of Goods Sold Incl. D&A10.9110.968.876.795.105.771.940.610.72
Gross Profit30.1233.0923.7613.6111.647.242.110.421.13
Selling, General and Administrative Excl. Other31.9828.1419.9114.1520.6020.2819.049.218.31
Research and Development2.321.350.670.580.571.101.251.181.66
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-1.864.953.85-0.54-8.95-13.04-16.93-8.79-7.18
Interest Expense2.146.2513.7815.6214.137.092.541.844.50
Unusual Expense-5.92-7.4325.099.62-12.807.0912.03-0.23-0.06
Net Income Before Taxes2.7311.90-33.06-25.80-10.29-27.23-30.94-10.43-11.63
Income Taxes0.070.090.030.000.000.030.000.000.00
Consolidated Net Income2.5711.81-33.08-25.81-10.29-27.26-30.94-10.43-11.63
Net Income From Continuing Operations2.5711.81-33.08-25.81-10.29-27.26-30.94-10.43-11.63
Net Income2.5711.81-33.08-25.81-10.29-27.26-30.94-10.43-11.63
EPS (Recurring)-0.87-0.16-3.48-9.01-13.14-16.13-22.33-19.56-29.27
EPS (Basic, Before Extraordinaries)0.301.38-7.41-12.19-7.02-19.72-30.68-19.26-29.17
EPS (Diluted)-0.390.41-7.41-12.19-7.02-19.72-30.68-19.26-29.17
EBITDA-0.446.234.990.49-8.00-11.81-15.92-8.73-7.16
Non-Operating Income (Expense)0.815.771.96-0.02-0.01-0.000.56-0.03-0.01
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense6.663.831.201.501.490.000.020.332.48
Price To Earnings Ratio7.827.82-------
Price To Sales Ratio-6.153.150.510.756.7717.2431.5818.59
Gross Margin73.4275.1272.8166.7369.5655.6552.1140.6961.30
Operating Margin-4.5411.2311.79-2.65-53.47-100.25-417.25-854.87-388.11
Net Margin6.2726.82-101.38-126.52-61.48-209.52-762.47-1,013.86-628.70
Shares Outstanding8.608.598.543.041.461.281.260.780.42
Market Capitalization16.1716.17196.2913.3412.5181.8887.0847.0035.80

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue8.589.749.6213.0911.4510.169.3410.33
Cost of Goods Sold Incl. D&A2.222.572.433.682.752.382.152.51
Gross Profit6.367.177.189.418.707.787.197.82
Selling, General and Administrative Excl. Other7.437.458.318.797.245.916.215.30
Research and Development0.430.630.660.610.340.190.210.15
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-1.07-0.28-1.120.611.471.880.992.52
Interest Expense0.280.520.550.801.721.871.852.63
Unusual Expense0.000.000.00-5.92-5.42-0.994.9012.66
Net Income Before Taxes-1.35-0.68-1.446.2010.321.05-5.68-12.72
Income Taxes0.060.010.000.000.000.000.000.03
Consolidated Net Income-1.42-0.68-1.446.1110.321.05-5.68-12.75
Net Income From Continuing Operations-1.42-0.68-1.446.1110.321.05-5.68-12.75
Net Income-1.42-0.68-1.446.1110.321.05-5.68-12.75
EPS (Recurring)-0.16-0.08-0.17-0.520.05-0.07-0.26-0.45
EPS (Basic, Before Extraordinaries)-0.16-0.08-0.170.711.200.12-0.66-1.49
EPS (Diluted)-0.16-0.08-0.170.020.460.01-0.66-1.49
EBITDA-0.690.07-0.811.001.802.181.262.93
Non-Operating Income (Expense)-0.010.120.230.465.160.060.090.05
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.171.241.472.781.101.131.10-
Price To Earnings Ratio7.8230.59------
Price To Sales Ratio-1.963.355.158.307.698.356.02
Gross Margin74.0873.6574.7071.8676.0076.5876.9975.73
Operating Margin-12.50-2.88-11.694.7012.8118.4710.5524.42
Net Margin-16.51-7.00-14.9646.6590.1710.38-60.76-123.46
Shares Outstanding8.608.608.598.598.588.578.558.54
Market Capitalization16.1785.99148.59255.91321.13281.14302.36196.29

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments11.9610.241.801.150.622.441.760.360.73
Short Term Receivables5.423.333.314.032.422.360.080.240.15
Inventories5.934.152.950.871.042.960.540.360.23
Other Current Assets1.310.681.720.570.330.180.130.130.09
Total Current Assets24.6318.409.786.624.407.932.501.081.20
Net Property, Plant & Equipment2.360.730.940.751.011.270.840.080.06
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets10.2910.9911.6912.4013.1013.81--0.00
Other Assets0.070.000.000.110.110.030.040.020.01
Total Assets37.3430.1222.4219.8718.6223.033.381.181.28
Short Term Debt Incl. Current Port. of LT Debt5.7925.6131.4540.6725.2117.046.4910.796.05
Accounts Payable3.253.735.714.407.644.451.441.591.50
Other Current Liabilities8.8016.0927.6015.1223.4114.684.494.103.50
Total Current Liabilities17.8545.4264.7560.1956.2636.1712.4216.4911.04
Long Term Debt17.180.190.490.440.990.530.460.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities---0.030.03----
Other Liabilities0.700.300.350.230.290.040.570.050.00
Total Liabilities35.7245.9165.5960.8857.5836.7513.4516.5311.04
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity1.62-15.79-43.18-41.01-38.96-13.72-10.06-15.36-9.76
Total Shareholders Equity1.62-15.79-43.18-41.01-38.96-13.72-10.06-15.36-9.76
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity1.62-15.79-43.18-41.01-38.96-13.72-10.06-15.36-9.76
Total Liabilities & Stockholders Equity37.3430.1222.4219.8718.6223.033.381.181.28
Book Value Per Share0.19-1.85-14.20-28.03-30.33-10.93-12.85-36.99-26.28
Tangible Book Value Per Share-1.01-3.14-18.04-36.50-40.53-21.93-12.85-36.99-26.28
Full-Time Employees55463138404323168
Price to Book Ratio5.80-1.20-0.20-0.38-2.10-6.35-4.67-2.33-3.73
Return on Assets35.02-125.95-122.05-53.48-130.91-234.29-457.48-946.97-485.00
Return on Invested Capital62.85--------
Quick Ratio1.050.310.110.100.060.140.160.040.09
Current Ratio1.380.410.150.110.080.220.200.070.11

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income2.5711.81-33.08-25.81-10.29-27.26-30.94-9.93-11.63
Depreciation1.421.281.151.030.951.241.010.060.02
Other Funds (Non Cash)1.16-5.2135.5917.54-6.7111.3815.842.247.19
Funds from Operations5.167.893.65-7.24-16.05-14.62-14.08-7.62-4.42
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-1.87-4.01-1.192.70-1.128.211.371.210.80
Cash from Operating Activities3.293.882.46-4.54-17.17-6.41-12.72-6.41-3.62
Capital Expenditures-0.91-1.94-0.490.000.00-0.53-20.05-0.05-0.04
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.020.330.000.000.00-
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.385.380.000.000.000.000.000.000.00
Cash from Investing Activities-0.533.43-0.490.020.33-0.53-20.05-0.05-0.04
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock0.270.5610.300.000.100.002.511.760.04
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.270.5610.300.000.100.002.511.760.04
Proceedsfrom Stock Options0.000.0010.300.000.000.002.450.000.00
Issuance or Reduction of Debt, Net-6.07-6.14-3.955.2117.283.219.463.303.28
Change in Long Term Debt-5.7521.60-0.21-0.17-3.220.34-4.990.000.00
Issuance of Long Term Debt0.0023.280.000.000.001.030.610.000.00
Reduction of Long Term Debt-5.75-1.68-0.21-0.17-3.22-0.69-5.600.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.001.9121.482.800.00
Other Financing Activities Uses0.000.000.000.000.00--0.000.00
Cash from Financing Activities-5.79-5.596.355.2117.385.1233.457.863.32
Exchange Rate Effect-0.000.12-0.05-0.01-0.00-0.000.00-0.02
Net Change in Cash-3.031.728.440.640.53-1.820.681.40-0.37
Free Cash Flow2.601.931.97-4.54-17.17-6.94-32.77-6.46-3.66
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow-140.1452.24------
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.030.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments6.579.3810.7811.969.608.50
Short Term Receivables4.965.806.005.424.623.85
Inventories6.727.075.905.936.815.91
Other Current Assets1.000.951.271.311.601.91
Total Current Assets19.2623.2023.9624.6322.6320.17
Net Property, Plant & Equipment3.263.212.902.362.422.24
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets9.9610.1510.1810.2910.4610.64
Other Assets0.040.050.060.070.080.00
Total Assets32.5236.6037.1037.3435.6033.05
Short Term Debt Incl. Current Port. of LT Debt6.745.605.885.795.8226.97
Accounts Payable3.153.313.323.253.994.00
Other Current Liabilities6.509.269.108.809.7715.53
Total Current Liabilities16.3918.1718.3017.8519.5846.50
Long Term Debt12.8615.1016.2817.1818.630.98
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.410.540.680.700.320.34
Total Liabilities29.6733.8235.2635.7238.5347.82
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity2.852.791.841.62-2.93-14.78
Total Shareholders Equity2.852.791.841.62-2.93-14.78
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity2.852.791.841.62-2.93-14.78
Total Liabilities & Stockholders Equity32.5236.6037.1037.3435.6033.05
Book Value Per Share0.330.320.210.19-0.34-1.72
Tangible Book Value Per Share-0.83-0.86-0.97-1.01-1.56-2.97
Full-Time Employees---55--
Price to Book Ratio5.8046.7691.72-87.31-21.73-16.24
Return on Assets7.5541.1047.2435.02-24.53-140.68
Return on Invested Capital-9.01-3.81-7.9432.5065.76-
Quick Ratio0.760.890.991.050.810.31
Current Ratio1.171.281.311.381.160.43

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-1.42-0.68-1.446.1110.321.05
Depreciation0.380.350.310.380.330.30
Other Funds (Non Cash)1.771.841.88-4.33-8.521.20
Funds from Operations0.731.510.752.162.142.55
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-1.58-1.08-0.361.16-1.05-1.56
Cash from Operating Activities-0.850.420.403.321.080.99
Capital Expenditures-0.21-0.45-0.16-0.10-0.53-1.16
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.385.000.00
Cash from Investing Activities-0.20-0.45-0.160.284.47-1.16
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.060.020.200.110.25
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.060.020.200.110.25
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-1.75-1.44-1.44-1.44-4.56-0.09
Change in Long Term Debt-1.44-1.44-1.44-1.4423.19-0.09
Issuance of Long Term Debt0.000.000.000.0023.280.00
Reduction of Long Term Debt-1.44-1.44-1.44-1.44-0.09-0.09
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities-1.75-1.38-1.42-1.24-4.450.16
Exchange Rate Effect--0.000.000.000.00
Net Change in Cash-2.81-1.40-1.182.361.11-0.01
Free Cash Flow-1.050.120.313.220.56-0.17
Price to Free Cash Flow-20.4437.88117.27--

Revenue breakdown

Consumables Parts And Accessories2024: 21.12M 2025: 25.80M
Extended Warranty2024: 95.00K 2025: 172.00K
License Fees2024: 45.00K 2025: 20.00K
Other2024: 306.00K 2025: 206.00K
System2024: 11.07M 2025: 17.85M
Non-US2024: 235.00K
United States2024: 32.40M 2025: 44.05M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-302.21%0.2M8.1M61.84K
2026-10-152.90%0.2M8.1M98.09K
2026-09-303.02%0.2M8.1M143.60K
2026-09-152.95%0.2M8.1M196.33K
2026-08-313.58%0.3M8.1M197.60K
2026-08-143.74%0.3M8.1M201.40K
2026-07-316.90%0.6M8.1M205.96K
2026-07-157.57%0.6M8.1M181.99K
2026-06-307.76%0.6M8.1M137.62K
2026-06-159.47%0.8M8.1M91.15K
2026-05-299.62%0.8M8.1M91.71K
2026-05-159.97%0.8M8.1M87.36K
2026-04-309.45%0.8M8.1M74.84K
2026-04-158.30%0.7M8.1M67.31K
2026-03-317.68%0.6M8.1M65.73K
2026-03-137.37%0.6M8.1M56.35K
2026-02-277.36%0.6M8.1M60.57K
2026-02-136.87%0.6M8.1M62.97K
2026-01-306.52%0.5M8.1M81.36K
2026-01-155.76%0.5M8.1M97.05K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-108-KCurrent report2026-11-10SEC
2026-11-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-288-KCurrent report2026-10-28SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-09-258-KCurrent report2026-09-23SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-068-KCurrent report2026-08-06SEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-31SCHEDULE 13G/ASEC
2026-07-30SCHEDULE 13G/ASEC
2026-07-138-KCurrent report2026-07-13SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-06-168-KCurrent report2026-06-16SEC
2026-06-158-KCurrent report2026-06-11SEC
2026-05-29SDSpecialized Disclosure ReportSEC
2026-05-128-KCurrent report2026-05-12SEC
2026-05-1210-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-044Statement of changes in beneficial ownership of securities2026-04-30SEC
2026-05-04SCHEDULE 13G/ASEC
2026-04-304Statement of changes in beneficial ownership of securities2026-04-28SEC
2026-04-29ARSAnnual report to security holders. 2025-12-31SEC
2026-04-29DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-0500170.47K1
2026-04002.02M5
2026-030000
2026-020000
2026-010000
2025-12005.01M6
2025-110000

Institutional holders

Manager% owned
Solas Capital Management, LLC7.11%
AWM Investment Company, Inc.5.29%
Praetorian PR LLC4.59%
VANGUARD CAPITAL MANAGEMENT LLC4.10%
Opaleye Management Inc.3.56%
UBS Group AG1.88%
BlackRock, Inc.1.86%
GEODE CAPITAL MANAGEMENT, LLC1.04%
CITADEL ADVISORS LLC0.69%
VANGUARD FIDUCIARY TRUST CO0.50%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND3.08%
VANGUARD EXTENDED MARKET INDEX FUND0.92%
Fidelity Small Cap Index Fund0.85%
Fidelity Extended Market Index Fund0.46%
VANGUARD RUSSELL 2000 INDEX FUND0.45%
iShares Micro-Cap ETF0.30%
Schwab Small-Cap Index Fund0.19%
Goldman Sachs Absolute Return Tracker Fund0.18%
Fidelity Total Market Index Fund0.16%
Fidelity Series Total Market Index Fund0.12%

OakChart. SNWV. Cached 15 minutes.